Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 10,764 m |
| EPS, EUR | 2.60 |
| P/B ratio | 6.5 |
| P/E ratio | 16.5 |
| Dividend yield | 0.00% |
| Revenue, EUR | 2,057 m |
| Net income, EUR | 694 m |
| Profit margin | 33.73% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Invesco Global Enhanced Equity UCITS ETF EUR PfHdg Acc | 0.07% | Equity World Multi-Factor Strategy | 8 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.89% | Equity United States Health Care Biotech | 46 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 531 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.02% | Equity North America Social/Environmental | 26 |
| Invesco Global Enhanced Equity UCITS ETF Acc | 0.07% | Equity World Multi-Factor Strategy | 575 |
| Invesco Global Enhanced Equity UCITS ETF GBP PfHdg Acc | 0.07% | Equity World Multi-Factor Strategy | 3 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.17% | Equity United States Small Cap | 210 |
| YTD | +11.91% |
| 1 month | +7.83% |
| 3 months | +16.65% |
| 6 months | +17.00% |
| 1 year | +13.29% |
| 3 years | +135.92% |
| 5 years | +113.96% |
| Since inception (MAX) | +113.54% |
| 2025 | +18.32% |
| 2024 | +50.00% |
| 2023 | +50.07% |
| 2022 | -13.33% |
| Volatility 1 year | 37.20% |
| Volatility 3 years | 35.28% |
| Volatility 5 years | 35.51% |
| Return per risk 1 year | 0.36 |
| Return per risk 3 years | 0.94 |
| Return per risk 5 years | 0.46 |
| Maximum drawdown 1 year | -24.69% |
| Maximum drawdown 3 years | -28.30% |
| Maximum drawdown 5 years | -33.03% |
| Maximum drawdown since inception | -34.12% |